Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Syndax Pharmaceuticals (SNDX) Inventory (2016 - 2025)

Historic Inventory for Syndax Pharmaceuticals (SNDX) over the last 9 years, with Q3 2025 value amounting to $25.0 million.

  • Syndax Pharmaceuticals' Inventory changed N/A to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $366000.0 for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Syndax Pharmaceuticals' Inventory stood at $25.0 million.
  • Syndax Pharmaceuticals' 5-year Inventory high stood at $25.0 million for Q3 2025, and its period low was $22000.0 during Q2 2021.
  • Moreover, its 3-year median value for Inventory was $2.5 million (2024), whereas its average is $8.0 million.
  • Examining YoY changes over the last 5 years, Syndax Pharmaceuticals' Inventory showed a top increase of 6184.21% in 2021 and a maximum decrease of 8503.4% in 2021.
  • Over the past 3 years, Syndax Pharmaceuticals' Inventory (Quarter) stood at $22000.0 in 2021, then surged by 1563.64% to $366000.0 in 2024, then soared by 6730.6% to $25.0 million in 2025.
  • Its last three reported values are $25.0 million in Q3 2025, $17.7 million for Q2 2025, and $4.7 million during Q1 2025.